Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2011-07-12
2011-07-12
Ulm, John D (Department: 1649)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252300, C435S320100, C514S04400A
Reexamination Certificate
active
07977069
ABSTRACT:
DNA encoding a cholecystokinin octapeptide sulfated form (CCK-8S) G-protein coupled receptor, a complementary strand thereof, a vector containing the DNA, a transformant containing the vector, a pharmaceutical composition, and a reagent kit are provided. Such DNA and constructs are useful in identifying a compound that inhibits or promotes a function of the protein and/or expression of a DNA encoding the protein. Such DNA and constructs are also useful for identifying an anti-depressant drug or a compound that has an anti-depressant action.
REFERENCES:
patent: 5874245 (1999-02-01), Fukusumi et al.
patent: 2003/0113798 (2003-06-01), Burmer et al.
patent: 2003/0143668 (2003-07-01), Suwa et al.
patent: 2003/0235833 (2003-12-01), Suwa et al.
patent: 2006/0134109 (2006-06-01), Gaitanaris et al.
patent: 10-84976 (1998-04-01), None
patent: 11-32766 (1999-02-01), None
patent: 2003-284573 (2003-10-01), None
patent: WO 02/061087 (2002-08-01), None
patent: WO 2005/049833 (2005-06-01), None
International Preliminary Report on Patentability for PCT/JP2004/017239 dated Aug. 3, 2006.
Dunlop et al., “Full and Partial Agonist Activity of C-terminal Cholecystokinin Peptides at the Cloned Human CCK-A Receptor Expressed in Chinese Hamster Ovary Cells,” Peptides, vol. 18, No. 6, 1997 (pp. 865-868).
Shiratsuchi et al., “Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1),” Cytogenetics and Cell Genetics, vol. 79, 1997 (pp. 103-108).
Nishimori et al., “A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis,” Oncogene, vol. 15, No. 18, Oct. 30, 1997 (pp. 2145-2150).
Kee et al., “Expression of Brain-Specific Angiogenesis Inhibitor 2 (BAI2) in Normal and Ischemic Brain: Involvement of BAI2 in the Ischemia-Induced Brain Angiogenesis,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, No. 9, 2002 (pp. 1054-1067).
Kaur et al., “Brain Angiogenesis Inhibitor 1 is Differentially Expressed in Normal Brain and Gliobastoma Independently of p53 Expression,” American Journal of Pathology, vol. 162, No. 1, Jan. 2003 (pp. 19-27).
Shiratsuchi et al. “Cloning and Characterization of BAI-Associated Protein 1: A PDZ Domain-Containing Protein That Interacts with BAI1,” Biochemical and Biophysical Research Communications, vol. 247, No. 3, Jun. 29, 1998 (pp. 597-604).
Ahrén et al., “Antidiabetogenic Action of Cholecystokinin-8 in Type 2 Diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, No. 3, 2000 (pp. 1043-1048).
Whalen et al., “Function Neuroimaging Studies of the Amygdala in Depression,” Seminars in Clinical Neuropsychiatry, vol. 7, No. 4, Oct. 2002 (pp. 234-242).
Drevets, “Neuroimaging Abnormalities in the Amygdala in Mood Disorders,” Ann. N.Y. Acad. Sci., vol. 985, 2003 (pp. 420-444).
Nestler et al., “Neurobiology of Depression,” Neuron, vol. 34, Mar. 28, 2002 (pp. 13-25).
Herranz, “Cholecystokinin Antagonists: Pharmacological and Therapetuic Potential,” Medicinal Research Reviews, vol. 23, No. 5, 2003 (pp. 559-605).
Nomoto et al., “Absence of the Cholecystokinin—A receptor deteriorates homeostasis of body temperature in response to changes in ambient temperature,” Am. J. Physiol. Regulatory Integrative Comp. Physiol., vol. 287, Sep. 2004 (pp. 556-561).
Miyasaka et al., “Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze,” Neuroscience Letters, vol. 335, No. 2, Dec. 25, 2002 (pp. 115-118).
Bi et al., “Actions of CCK in the controls of food intake and body weight: Lessons from the CCK-A receptor deficient OLETF rat,” Neoropeptides, vol. 36, Nos. 2 & 3, Apr./Jun. 2002 (pp. 171-181).
Noble et al., “Phenotypes of mice with invalidation of cholecystokinin (CCK1or CCK2) receptors,” Neoropeptides, vol. 36, Nos. 2 & 3), 2002 (pp. 157-170).
Horinouchi et al., “Reduced anxious behavior in mice lacking the CCk2 receptor gene,” European Neurophyschopharmacology, vol. 14, 2004 (pp. 157-161).
Daugé et al., “Behavioral Profile of CCK2 Receptor-deficient Mice,” Neuropsychopharmacology, vol. 25, No. 5, 2001 (pp. 690-698).
Kurrikoff et al., “Deletion of the CCK2 receptor gene reduced mechanical sensitivity and abolishes the developement of hyperalgesia in mononeuropathic mice,” European Journal of Neuroscience, vol. 20, 2004 (pp. 1577-1586).
Database Geneseq No. XP-002435010, “Human GPCR protein SEQ ID No. 870,” Jan. 1, 2004 (2 pages).
Database UniProt No. XP-002435011, “Brain-specific angiogenesis inhibtior 2 precursor,” Jul. 11, 2006 (4 pages).
Database Geneseq No. XP-002435012, “Human brain-specific angiogenesis inhibitor 2 protein SEQ ID No. 344,” dated Mar. 4, 2003 (2 pages).
Bree et al., “Homolateral Cerebrocortical Changes in Neuropeptide and Receptor Expression After Minimal Cortical Infarction,” Neuroscience, vol. 69, No. 3, 1995 (pp. 847-858).
Supplementary Partial European Search Report for European Patent Application No. 04 81 8967 dated May 24, 2007.
Notification of Transmittal of Translation of the International Preliminary Report on Patentability for International Application No. PCT/JP2006/309118, dated Nov. 15, 2007, eight pages.
Extended European Search Report from counterpart European Patent Application No. 06745969.3 dated Jul. 28, 2008 (7 pages).
Kombian et al., “Cholecystokinin activates CCK8receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro,” Journal of Physiology, vol. 555, No. 1, Feb. 15, 2004, pp. 71-84.
Database MGI, “Phenotypic Allele Detail,” Sep. 2005 (1 page).
Flumann et al., “A Human Orphan Calcitonin Receptor-Like Structure,” Jan. 5, 1995, BBRC 206(1): 341-347.
Eva et al., Molecular Cloning of a Novel G protein-coupled Receptor that may belong to the Neuropeptide Receptor Family, Oct. 1990, FEBS Letters 271 (1,2): 81-84.
Nagase Takahiro
Ohara Osamu
Ohishi Michio
Okajima Daisuke
Yokota Hiroshi
Daiichi Sankyo Company, Limited
Kazusa DNA Research Institute Foundation
Kilyk & Bowersox P.L.L.C.
Ulm John D
LandOfFree
DNA encoding a CCK-8S G-protein coupled receptor, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding a CCK-8S G-protein coupled receptor, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding a CCK-8S G-protein coupled receptor, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2734050